The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
ID: ALA1487784
Max Phase: Preclinical
Molecular Formula: C13H9N3O
Molecular Weight: 223.24
Molecule Type: Small molecule
Associated Items:
Representations Canonical SMILES: c1ccc(-c2nc(-c3ccncc3)no2)cc1
Standard InChI: InChI=1S/C13H9N3O/c1-2-4-11(5-3-1)13-15-12(16-17-13)10-6-8-14-9-7-10/h1-9H
Standard InChI Key: KVLYQZJFVKRLHI-UHFFFAOYSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Properties Molecular Weight: 223.24Molecular Weight (Monoisotopic): 223.0746AlogP: 2.80#Rotatable Bonds: 2Polar Surface Area: 51.81Molecular Species: NEUTRALHBA: 4HBD: 0#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0CX Acidic pKa: CX Basic pKa: 2.66CX LogP: 2.97CX LogD: 2.97Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.67Np Likeness Score: -1.72
References 1. PubChem BioAssay data set, 2. PubChem BioAssay data set, 3. Zhang YY,Zhang QQ,Zhang J,Song JL,Li JC,Han K,Huang JT,Jiang CS,Zhang H. (2020) Synthesis and evaluation of 1,2,4-oxadiazole derivatives as potential anti-inflammatory agents by inhibiting NF-κB signaling pathway in LPS-stimulated RAW 264.7 cells., 30 (17.0): [PMID:32738985 ] [10.1016/j.bmcl.2020.127373 ]